Liver Biopsy Clinical Trial
Official title:
INJ-LIVERB-01 Identification of Liver Tumours Using BIP - Biopsy System
Verified date | November 2018 |
Source | Injeq Ltd |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This clinical device investigation is conducted by performing liver biopsies using the BIP - Biopsy Tool. The aim is to assess the feasibility of bioimpedance spectroscopy based biopsy tool guidance method and test how well BIP biopsy system is able to distinguish liver tumours from surrounding tissue. In addition, user feedback is obtained to improve the usability of the investigational device. The study does not affect the traditional treatment procedure and only the patients in clinical need for diagnosis by liver biopsy are included on voluntary basis. The invasive products used in actual biopsy operation are designed so that their performance is essentially equal to the currently used biopsy devices, the only difference is the measurement capability of biopsy needle and connection to measurement device.
Status | Completed |
Enrollment | 26 |
Est. completion date | November 2018 |
Est. primary completion date | December 31, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Consenting adults undergoing ultrasound-guided core liver biopsy to diagnose liver tumour or other abnormalities - Identifiable non-tumorous liver tissue along the planned needle injection path. Exclusion Criteria: - Inability to give informed consent - Being under aged - Being pregnant - Being high risk patient - Lack of identifiable non-tumorous liver tissue along the injection path to the tumour location - Known contraindications to liver biopsy. |
Country | Name | City | State |
---|---|---|---|
Finland | Helsinki University Hospital, Department of Radiology | Helsinki | HUS |
Lead Sponsor | Collaborator |
---|---|
Injeq Ltd |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in mean between measured bioimpedance spectra from tumorous and nontumorous tissue | Liver biopsy is performed in traditional way but with biopsy needle that enables bioimpedance measurement from multiple frequencies (spectrum). Tumorous and nontumorous tissue is measured during ultrasound guided biopsy procedure and the tumorous tissue type is verified by histological biopsy sample analysis. The bioimpedance spectra (impedance and phase angle) are compared with each other and differences in means of the spectra calculated. The data analysis is performed offline. | During liver biopsy (couple of minutes/patient) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00643656 -
Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
|
Phase 4 | |
Enrolling by invitation |
NCT04170452 -
Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta
|
||
Recruiting |
NCT03142698 -
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
|
N/A | |
Withdrawn |
NCT03910790 -
Liver Biopsy Using a 19 Gauge Fine Needle Biopsy Needle
|
N/A | |
Recruiting |
NCT03173287 -
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI
|
N/A | |
Completed |
NCT04003766 -
Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy
|
N/A | |
Terminated |
NCT02573545 -
Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case
|
N/A | |
Withdrawn |
NCT04039529 -
Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy
|
N/A | |
Terminated |
NCT03040323 -
Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses
|
Phase 4 | |
Recruiting |
NCT05614973 -
Efficacy and Safety of Percutaneous Liver Biopsy With Needle Tract Plugging on Outpatient Basis
|
N/A |